The Association Between Depression and Substance Use Among Primary Care Patients With Comorbid Medical and Behavioral Health Conditions.

Mark P McGovern, Julia Dunn, Levi N Bonnell, George Leibowitz, Elizabeth Waddell, Gail Rose, Benjamin Littenberg
Author Information
  1. Mark P McGovern: Stanford University School of Medicine, Palo Alto, CA, USA. ORCID
  2. Julia Dunn: Stanford University School of Medicine, Palo Alto, CA, USA. ORCID
  3. Levi N Bonnell: University of Vermont, Burlington, VT, USA.
  4. George Leibowitz: Stony Brook University, Stony Brook, NY, USA.
  5. Elizabeth Waddell: Oregon Health & Science University, Portland, OR, USA. ORCID
  6. Gail Rose: University of Vermont, Burlington, VT, USA. ORCID
  7. Benjamin Littenberg: University of Vermont, Burlington, VT, USA.

Abstract

INTRODUCTION: The scope of primary care increasingly encompasses patient behavioral health problems, manifest typically through depression screening and treatment. Although substance Use is highly comorbid with depression, it is not commonly identified and addressed in the primary care context. This study aimed to examine the association between the likelihood of substance Use disorder and increased depression severity, both cross-sectionally and longitudinally, among a sample of 2409 patients from 41 geographically dispersed and diverse primary care clinics across the US.
METHODS: This is secondary analysis of data obtained from a multi-site parent study of integrated behavioral health in primary care, among patients with both chronic medical and behavioral health conditions. Patient reported outcome surveys were gathered from patients at 3 time points. The primary care practices were blind to which of their patients completed surveys. Included were standardized measures of depression severity (Patient Health Questionnaire-9) [PHQ-9] and substance Use disorder likelihood (Global Appraisal of Individual Needs-Short Screener [GSS]).
RESULTS: Four percent of the study population screened positive for substance Use disorder. PHQ-9 scores indicated depression among 43% of all patients. There was a significant association between the likelihood of substance Use disorder and depression initially, at a 9-month follow-up, and over time. These associations remained significant after adjusting for age, gender, race, ethnicity, education, income, and other patient and contextual characteristics.
CONCLUSIONS: The findings suggest that substance Use disorder is associated with depression severity cross-sectionally and over time. Primary care clinics and health systems might consider implementing substance Use screening in addition to the more common screening strategies for depression. Especially for patients with severe depression or those who do not respond to frontline depression treatments, the undermining presence of a substance Use disorder should be explored.

Keywords

References

  1. Addiction. 2005 Jan;100(1):70-8 [PMID: 15598194]
  2. Curr Opin Psychiatry. 2012 May;25(3):165-71 [PMID: 22449770]
  3. Med Clin North Am. 2018 Jul;102(4):567-586 [PMID: 29933816]
  4. Addict Behav. 2012 Jan;37(1):11-24 [PMID: 21981788]
  5. Psychol Med. 2014 Mar;44(4):797-810 [PMID: 23795762]
  6. J Affect Disord. 2020 Apr 1;266:288-304 [PMID: 32056890]
  7. J Subst Abuse Treat. 2013 Apr;44(4):375-83 [PMID: 23098381]
  8. J Adolesc Health. 2003 Dec;33(6):436-57 [PMID: 14642706]
  9. Am J Psychiatry. 2006 Jan;163(1):125-32 [PMID: 16390899]
  10. Transl Behav Med. 2012 Sep;2(3):337-44 [PMID: 24073133]
  11. J Affect Disord. 2021 Jan 15;279:473-483 [PMID: 33126078]
  12. J Gen Intern Med. 2014 Mar;29(3):491-9 [PMID: 24165926]
  13. Psychosomatics. 2002 Sep-Oct;43(5):405-12 [PMID: 12297610]
  14. J Am Board Fam Med. 2021 Jul-Aug;34(4):688-697 [PMID: 34312262]
  15. Health Serv Res. 2013 Apr;48(2 Pt 1):539-59 [PMID: 22816561]
  16. Drug Alcohol Depend. 2009 Jan 1;99(1-3):248-60 [PMID: 18986774]
  17. J Psychoactive Drugs. 2012 Sep-Oct;44(4):307-17 [PMID: 23210379]
  18. Psychiatr Serv. 2015 Mar 1;66(3):285-94 [PMID: 25727117]
  19. Ann Intern Med. 2016 Nov 15;165(10):690-699 [PMID: 27595276]
  20. J Prim Care Community Health. 2021 Jan-Dec;12:21501327211049053 [PMID: 34670441]
  21. J Subst Abuse Treat. 2009 Sep;37(2):127-37 [PMID: 19150207]
  22. J Gen Intern Med. 2019 Dec;34(12):2898-2900 [PMID: 31093839]
  23. Gen Hosp Psychiatry. 2018 Jul - Aug;53:1-11 [PMID: 29698902]
  24. J Gen Intern Med. 2020 Dec;35(Suppl 3):918-926 [PMID: 33145686]
  25. Prim Care Companion CNS Disord. 2019 Feb 14;21(1): [PMID: 30762976]
  26. Addiction. 2017 Feb;112 Suppl 2:23-33 [PMID: 28074571]
  27. Drug Alcohol Depend. 2008 Nov 1;98(1-2):45-53 [PMID: 18571875]
  28. Br J Psychiatry. 1995 Feb;166(2):199-204 [PMID: 7728364]
  29. Psychiatr Serv. 2020 Apr 1;71(4):312-318 [PMID: 31847739]
  30. Addict Behav. 2017 Oct;73:133-136 [PMID: 28511097]
  31. J Subst Abuse Treat. 2020 Mar;110:18-27 [PMID: 31952624]
  32. J Clin Psychol Med Settings. 2013 Dec;20(4):415-26 [PMID: 23744107]
  33. Acad Psychiatry. 2018 Apr;42(2):265-268 [PMID: 29488173]
  34. Addiction. 2017 Feb;112 Suppl 2:110-117 [PMID: 28074569]
  35. Trials. 2021 Mar 10;22(1):200 [PMID: 33691772]
  36. J Clin Nurs. 2016 Nov;25(21-22):3131-3143 [PMID: 27140392]
  37. JAMA. 2016 Aug 23-30;316(8):826-34 [PMID: 27552616]
  38. Psychiatr Serv. 2019 Oct 1;70(10):940-943 [PMID: 31185852]
  39. Curr Opin Psychiatry. 2008 Jan;21(1):14-8 [PMID: 18281835]
  40. J Gen Intern Med. 2018 Mar;33(3):335-346 [PMID: 28948432]
  41. Am J Addict. 2006;15 Suppl 1:80-91 [PMID: 17182423]
  42. J Clin Psychiatry. 2012 Jun;73(6):865-73 [PMID: 22480900]
  43. J Emerg Nurs. 2018 Jan;44(1):26-32 [PMID: 28802869]
  44. Curr Psychiatry Rep. 2019 Jan 19;21(1):4 [PMID: 30661126]
  45. Am J Med. 2005 Apr;118(4):330-41 [PMID: 15808128]
  46. Am J Drug Alcohol Abuse. 2020;46(2):251-261 [PMID: 31935133]
  47. J Psychiatr Res. 2017 Aug;91:47-56 [PMID: 28314128]
  48. Exp Clin Psychopharmacol. 2010 Dec;18(6):562-9 [PMID: 21186931]
  49. Subst Abus. 2022;43(1):240-244 [PMID: 34086531]
  50. Ann Fam Med. 2017 Jul;15(4):306-308 [PMID: 28694263]
  51. JAMA Intern Med. 2017 Oct 1;177(10):1480-1488 [PMID: 28846769]
  52. Fam Med. 2022 May;54(5):389-394 [PMID: 35536625]
  53. Ann Fam Med. 2010 Jul-Aug;8(4):348-53 [PMID: 20644190]
  54. J Subst Abuse Treat. 2014 Feb;46(2):106-12 [PMID: 24095002]
  55. JAMA. 2020 Jun 09;323(22):2301-2309 [PMID: 32515821]
  56. Science. 2019 Mar 29;363(6434):1367 [PMID: 30923197]
  57. J Gen Intern Med. 2001 Sep;16(9):606-13 [PMID: 11556941]
  58. Addict Behav. 2017 May;68:14-17 [PMID: 28088053]
  59. Addict Sci Clin Pract. 2018 Apr 9;13(1):8 [PMID: 29628018]

MeSH Term

Humans
Depression
Comorbidity
Depressive Disorder
Substance-Related Disorders
Primary Health Care

Word Cloud

Created with Highcharts 10.0.0depressionsubstanceusecareprimarydisorderpatientshealthbehavioralscreeningstudylikelihoodseverityamongtimepatientassociationcross-sectionallyclinicsintegratedPatientsurveysHealthsignificantPrimaryINTRODUCTION:scopeincreasinglyencompassesproblemsmanifesttypicallytreatmentAlthoughhighlycomorbidcommonlyidentifiedaddressedcontextaimedexamineincreasedlongitudinallysample240941geographicallydisperseddiverseacrossUSMETHODS:secondaryanalysisdataobtainedmulti-siteparentchronicmedicalconditionsreportedoutcomegathered3pointspracticesblindcompletedIncludedstandardizedmeasuresQuestionnaire-9[PHQ-9]GlobalAppraisalIndividualNeeds-ShortScreener[GSS]RESULTS:FourpercentpopulationscreenedpositivePHQ-9scoresindicated43%initially9-monthfollow-upassociationsremainedadjustingagegenderraceethnicityeducationincomecontextualcharacteristicsCONCLUSIONS:findingssuggestassociatedsystemsmightconsiderimplementingadditioncommonstrategiesEspeciallysevererespondfrontlinetreatmentsunderminingpresenceexploredAssociationDepressionSubstanceUseAmongCarePatientsComorbidMedicalBehavioralConditions

Similar Articles

Cited By

No available data.